Formulate Labs, Inc. — Form D
Formulate Labs, Inc. of Fenton, MO, a company, filed a Form D exempt-offering notice with the SEC on 2025-07-10. The offering totals $6.9M, of which $1.4M was reported sold. Industry: Other.
Offering
- Filed: 2025-07-10
- Form: D
- Accession: 0001827318-25-000002
- Industry: Other
- Exemptions: 06b
- Total offering: $6.9M
- Amount sold: $1.4M
- Remaining: $5.5M
- Investors: 21
- Date of first sale: 2025-06-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-551363
Issuer
- Name: Formulate Labs, Inc.
- CIK: 0001827318
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 1645 Headland Dr., Fenton, MO, 63026
- Phone: 312-283-4854
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Michael Savino | Director | Fenton, MO |
| Osmaan Shah | Director | Fenton, MO |
| Osmaan Shah | Executive Officer | Fenton, MO |
| Jason Calacanis | Director | Los Angeles, CA |
Other filings by this issuer (1)
More